scholarly article | Q13442814 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | Horning SJ | |
Hoppe RT | |||
Yuen AR | |||
Halpern JD | |||
P433 | issue | 3 | |
P304 | page(s) | 814-822 | |
P577 | publication date | 1997-02-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease | |
P478 | volume | 89 |
Q51742964 | A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma. |
Q39195424 | Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience. |
Q74234766 | CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma |
Q37146056 | Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up |
Q27022992 | Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant |
Q35117413 | Current therapies in Hodgkin's disease |
Q34095620 | Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma |
Q53080371 | Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients. |
Q53315058 | Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. |
Q41909027 | High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables |
Q37577385 | High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging |
Q37238152 | High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience |
Q35735986 | Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report |
Q42742589 | Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma |
Q34501005 | Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas |
Q42433067 | Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution |
Q37254806 | Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure |
Q34064220 | Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma |
Q34495333 | Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography |
Q36404763 | Role of hematopoietic stem cell transplantation in relapsed/refractory hodgkin lymphoma |
Q35930635 | Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy |
Q90413312 | Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission |
Q37411665 | Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study |
Q34214895 | Upfront transplantation for poor-risk aggressive non-Hodgkin lymphoma and Hodgkin's disease: who benefits? |
Search more.